


Ask a doctor about a prescription for ATORVASTATIN TARBIS 10 mg FILM-COATED TABLETS
Patient Information Leaflet
Atorvastatina Tarbis10mg film-coated tablets EFG
Read the entire leaflet carefully before starting to take the medicine.
Contents of the package leaflet
Atorvastatina Tarbis belongs to a group of medicines known as statins, which are lipid-regulating medicines.
Atorvastatina Tarbis is used to reduce lipids such as cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes on their own have failed. If you have a high risk of heart disease, Atorvastatina Tarbis can also be used to reduce this risk even if your cholesterol levels are normal. During treatment, you should follow a standard low-cholesterol diet.
Do not take Atorvastatina Tarbis
Be especially careful with Atorvastatina Tarbis
Consult your doctor or pharmacist before starting to take Atorvastatina Tarbis.
For the following reasons, Atorvastatina Tarbis may not be suitable for you:
Talk to your doctor or pharmacist before taking Atorvastatina Tarbis
In any of these cases, your doctor may indicate that you should have blood tests before and, possibly, during treatment with Atorvastatina Tarbis to predict the risk of muscle-related side effects. It is known that the risk of muscle-related side effects (e.g., rhabdomyolysis) increases when certain medicines are taken at the same time (see section 2 "Using other medicines").
Also, inform your doctor or pharmacist if you experience constant muscle weakness. You may need additional tests and medicines to diagnose and treat this problem.
While you are taking this medicine, your doctor will check if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugars and fats in the blood, are overweight, and have high blood pressure.
Using Atorvastatina with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
There are some medicines that can affect the proper functioning of Atorvastatina Tarbis or the effects of these medicines may be modified by Atorvastatina Tarbis. This type of interaction can decrease the effect of one or both medicines. Alternatively, this combined use can increase the risk or severity of side effects, including serious muscle damage, known as rhabdomyolysis, described in Section 4:
Taking Atorvastatina Tarbis with food and drinks
See section 3 for instructions on how to take Atorvastatina Tarbis. Please note the following:
Grapefruit juice
Do not drink more than one or two small glasses of grapefruit juice per day, as large quantities of grapefruit juice can alter the effects of Atorvastatina Tarbis.
Alcohol
Avoid drinking large amounts of alcohol while taking this medicine. See the details in Section 2 "Be especially careful with Atorvastatina Tarbis".
Pregnancy and breastfeeding
Do not take Atorvastatina Tarbis if you are pregnant, think you may be pregnant, or are trying to become pregnant.
Do not take Atorvastatina Tarbis if you are of childbearing age and do not use adequate contraceptive measures.
Do not take Atorvastatina Tarbis if you are breastfeeding your child.
The safety of Atorvastatina Tarbis during pregnancy and breastfeeding has not been established.
Consult your doctor or pharmacist before using any medicine.
Driving and using machines
Do not drive if this medicine affects your ability to drive. Do not use tools or machines if this medicine affects your ability to use them.
Before starting treatment, your doctor will put you on a low-cholesterol diet, which you should also follow during treatment with Atorvastatina Tarbis.
The initial normal dose of Atorvastatina Tarbis is 10 mg once a day in adults and children from 10 years of age. Your doctor may increase it if necessary until you reach the dose you need. Your doctor will adjust the dose at intervals of 4 weeks or more. The maximum dose of Atorvastatina Tarbis is 80 mg once a day for adults and 20 mg once a day for children.
The tablets of Atorvastatina Tarbis should be swallowed whole with a glass of water and can be taken at any time of the day with or without food. However, try to take your tablet at the same time every day.
Follow your doctor's instructions for taking Atorvastatina Tarbis exactly. Consult your doctor or pharmacist if you have any doubts.
Your doctor will decide the duration of treatment with Atorvastatina Tarbis
Ask your doctor if you think the effect of Atorvastatina Tarbis is too strong or too weak.
If you take more Atorvastatina Tarbis than you should
If you accidentally take too many Atorvastatina Tarbis tablets (more than your usual daily dose), consult your doctor or the nearest hospital or call the Toxicology Information Service, phone 91 562 04 20.
If you forget to take Atorvastatina Tarbis
If you forget to take a dose, take the next scheduled dose at the correct time. Do not take a double dose to make up for missed doses.
If you stop treatment with Atorvastatina Tarbis
If you have any other questions about the use of this medicine or want to stop treatment, ask your doctor or pharmacist.
Like all medicines, Atorvastatina Tarbis can cause side effects, although not everyone gets them.
If you notice any of the following serious side effects, stop taking these tablets and inform your doctor immediately or go to the emergency department of the nearest hospital.
Rare: affects between 1 and 10 out of 10,000 patients:
Very rare: affects less than 1 in 10,000 patients:
Other possible side effects with Atorvastatina Tarbis:
Common side effects (affect between 1 and 10 out of 100 patients) include:
Uncommon side effects (affect between 1 and 10 out of 1,000 patients) include:
Rare side effects (affect between 1 and 10 out of 10,000 patients) include:
Very rare side effects (affect less than 1 in 10,000 patients) include:
Lupus-like disease (including rash, joint disorders, and effects on blood cells).
Frequency not known: Possible side effects of some statins (medicines of the same type):
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: a. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of the reach and sight of children.
Do not store above 30°C.
Do not use Atorvastatina Tarbis after the expiration date that appears on the blister pack and on the outer packaging after EXP. The expiration date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Atorvastatina Tarbis
Each film-coated tablet contains 10 mg of atorvastatin (as atorvastatin calcium trihydrate).
The other ingredients (excipients) are: microcrystalline cellulose, anhydrous sodium carbonate, maltose, sodium croscarmellose, magnesium stearate.
The coating of Atorvastatina Tarbis contains hypromellose, hydroxypropylcellulose, triethyl citrate, polysorbate 80, titanium dioxide (E-171).
Appearance of Atorvastatina Tarbis and packaging contents
The film-coated tablets of Atorvastatina Tarbis 10 mg are elliptical, concave, and white.
Atorvastatina Tarbis 10 mg is available in cartons with blister packs containing 28 film-coated tablets and in clinical packs containing 500 film-coated tablets.
Marketing authorization holder and manufacturer
Marketing authorization holder:
TARBIS FARMA, S.L.
Gran Vía Carlos III, 94.
08028 Barcelona, Spain.
Manufacturer:
TEVA PHARMA, S.L.U.
Polígono Malpica, Calle C nº 4.
50016 Zaragoza, Spain.
Date of last revision of this leaflet: April 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of ATORVASTATIN TARBIS 10 mg FILM-COATED TABLETS in December, 2025 is around 4.09 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ATORVASTATIN TARBIS 10 mg FILM-COATED TABLETS – subject to medical assessment and local rules.